Package Leaflet: Information for the User
Lamotrigine Kern Pharma 200 mg dispersible/chewable tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information:
Lamotrigine Kern Pharma belongs to a group of medicines called antiepileptics. It can be used for the treatment of two conditions: epilepsy and bipolar disorder.
Lamotrigine Kern Pharma is used for the treatment of epilepsybecause it blocks the signals in the brain that trigger seizures (attacks).
Lamotrigine Kern Pharma is also used for the treatment of bipolar disorder. People with bipolar disorder (formerly called manic-depressive disorder) suffer from radical mood swings, with periods of mania (excitement or euphoria) alternating with periods of depression (deep sadness or despair). In adults over 18 years of age, Lamotrigine Kern Pharma can be used to prevent the depressive episodes that occur in bipolar disorder, either alone or in combination with other medicines. It is not known how lamotrigine works in the brain to have this effect.
Do not take Lamotrigine Kern Pharma
If this is the case:
Warnings and precautions
Before taking lamotrigine, your doctor needs to know:
If this is the case:
It is essential to be aware of the symptoms:
Ask your doctor for help immediately if, after starting to take this medicine, you show any of these symptoms:
These symptoms include:
It is more likely that these symptoms will occur during the first few months of treatment with lamotrigine, especially if you start treatment with a dose that is too high or if your dose is increased too quickly; it is also more likely to occur if you are taking this medicine with another medicine called valproate. Children are more likely than adults to suffer from these side effects.
If the symptoms listed above are not treated, they can become more serious problems, such as organ failure or a severe skin disease.
Life-threatening skin rashes (Stevens-Johnson syndrome and toxic epidermal necrolysis) have been described with the use of lamotrigine, initially appearing as red, circular spots, often with a central blister.
Other additional signs that may appear are sores in the mouth, throat, nose, genitals, and conjunctivitis (swollen and red eyes).
These life-threatening skin rashes are often accompanied by flu-like symptoms. The rash can progress to the formation of widespread blisters or peeling of the skin.
The period of highest risk of severe skin reactions is during the first few weeks of treatment.
This risk may be associated with a genetic variant in people of Asian origin (mainly Chinese Han and Thai). If you are of such origin and have been detected with this genetic variant (HLA-B* 1502), talk to your doctor before taking lamotrigine.
If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of lamotrigine, you should not use lamotrigine again at any time.
If you develop a rash or these skin symptoms, stop taking lamotrigine, go to a doctor immediately, and inform them that you are taking this medicine. Your doctor will decide whether you need to undergo tests to assess liver, kidney, or blood function.
Thoughts of self-harm or suicide:
Antiepileptic medicines are used to treat different diseases, including epilepsy and bipolar disorder. People with bipolar disorder may have had thoughts of self-harm or suicide on occasion. If you have bipolar disorder, you may be more likely to have these thoughts in the following situations:
If you have thoughts or experiences that worry you, or if you notice that you feel worse or develop new symptoms while taking lamotrigine:
A small number of people who were treated with antiepileptics like lamotrigine have also had thoughts of self-harm or suicide. If you have these thoughts at any time, contact your doctor immediately.
If you are taking Lamotrigine Kern Pharma for epilepsy:
In some types of epilepsy, during treatment with lamotrigine, seizures may occasionally worsen or occur more frequently. Some patients may experience severe seizures that can cause serious health problems. If you notice that you are having seizures more often or if you experience severe seizures while taking this medicine:
Lamotrigine should not be given to children under 18 years of age for the treatment of bipolar disorder. Medicines for the treatment of depression and other mental health problems increase the risk of suicidal thoughts and behaviors in children and adolescents under 18 years of age.
Brugada syndrome
Brugada syndrome is a genetic disease that causes abnormal electrical activity in the heart. Lamotrigine may cause abnormalities in the electrocardiogram (ECG) that can lead to arrhythmias (abnormal heart rhythm). Consult your doctor if you have this disease.
Hemophagocytic lymphohistiocytosis (HLH)
Cases of a rare but very serious reaction of the immune system have been reported in patients taking lamotrigine. Contact your doctor or pharmacist immediately if you experience any of the following symptoms while taking lamotrigine: fever, rash, neurological symptoms (e.g., spasms or tremors, confusion, changes in brain function).
Pregnancy and breastfeeding
If you are breastfeeding or plan to start breastfeeding, consult your doctor or pharmacist before using this medicine. The active ingredient of Lamotrigine Kern Pharma passes into breast milk and may affect your baby. Your doctor will discuss the risks and benefits of breastfeeding while taking this medicine and will perform periodic reviews of your baby if you decide to start breastfeeding, as it may cause drowsiness, rash, or poor weight gain. Inform your doctor if you notice any of these symptoms in your baby.
Using Lamotrigine Kern Pharma with other medicines
Tell your doctor or pharmacist that you are using, have recently used, or might use any other medicines.
If you are using certain medicines, your doctor may need to check the dose of lamotrigine. These include:
Some medicines interact with lamotrigine or make it more likely to cause side effects. These include:
Hormonal contraceptives (such as the Pill) may affect how this medicine works. Your doctor may recommend that you use a specific hormonal contraceptive or another method of contraception, such as condoms, diaphragm, or IUD. If you are taking a hormonal contraceptive like the Pill, your doctor may ask you to have blood tests to check the level of lamotrigine. If you are thinking of starting to use a hormonal contraceptive:
It is possible that the administration of lamotrigine may alter the effect of hormonal contraceptives, although it is unlikely to reduce their effectiveness. If you are using a hormonal contraceptive and experience changes in your menstrual cycle, such as intermenstrual bleeding or spotting:
Pregnancy and breastfeeding
You should not stop treatment for epilepsy while pregnant. However, there is a higher risk of birth defects in newborns whose mothers took lamotrigine during pregnancy. These defects include cleft lip or palate. Your doctor may advise you to take folic acid supplements if you are planning to become pregnant and during pregnancy.
Pregnancy may alter the effectiveness of treatment with lamotrigine, so your doctor may ask you to have a blood test to check the levels of lamotrigine and adjust your dose accordingly.
Driving and using machines
Lamotrigine may cause symptoms such as drowsiness, dizziness, or changes in vision, and may reduce your reaction time. These effects, as well as the disease itself, may make it difficult for you to drive vehicles or operate machines. Therefore, do not drive, operate machines, or engage in other activities that require special attention until your doctor assesses your response to this medicine.
Lamotrigine Kern Pharma contains sorbitol
This medicine contains sorbitol. If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
Lamotrigine Kern Pharma contains sodium
Patients on low-sodium diets should note that this medicine contains 1.64 mg (0.072 mmol) of sodium per 200 mg.
Follow the instructions for taking this medicine exactly as indicated by your doctor. If you are in doubt, consult your doctor or pharmacist again.
What dose of Lamotrigina Kern Pharma to take:
It may take some time for your doctor to find the most suitable dose of lamotrigine for you. The dose you should take will depend on:
Your doctor will ask you to start treatment with a low dose and gradually increase the dose until you reach the most suitable dose for you (called the effective dose). Never take more lamotrigine than your doctor has prescribed.
Normally, the effective dose of lamotrigine for adults and children over 12 years of age is between 100 mg and 400 mg per day.
For children between 2 and 12 years of age, the effective dose depends on their body weight, usually between 1 mg and 15 mg per kilogram of body weight, up to a maximum of 400 mg per day.
How to take the dose of Lamotrigina Kern Pharma:
Take your dose of lamotrigine once or twice a day, as advised by your doctor. You can take it with or without food.
Your doctor may advise you to start or stop taking other medicines, depending on the conditions you are being treated for and how you respond to treatment.
Take the dispersible tablets of lamotrigine by swallowing them whole with a little water or by dissolving them in water:
If you chew the tablet:
You may need to drink a little more water to help the tablet dissolve in your mouth. After swallowing, drink a little more water to make sure you have taken all the medicine.
To dissolve the medicine (make a liquid medicine):
If you take more Lamotrigina Kern Pharma than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
Someone who takes too much lamotrigine may have some of these symptoms:
If you forget to take Lamotrigina Kern Pharma
Do not take an extra tablet or a double dose to make up for forgotten doses.
If you have not taken a dose of lamotrigine:
Do not stop taking Lamotrigina Kern Pharma without your doctor's advice.
You must take this medicine for as long as your doctor recommends. Do not stop treatment until your doctor tells you to.
If you are taking Lamotrigina Kern Pharma for the treatment of epilepsy:
To stop taking this medicine, it is essential to reduce the dose gradually over approximately 2 weeks. If you stop taking lamotrigine suddenly, you may experience seizures again or your condition may worsen.
If you are taking Lamotrigina Kern Pharma for bipolar disorder:
This medicine may take some time to work, so it is unlikely that you will feel better immediately. To stop taking lamotrigine, you do not need to reduce the dose gradually. However, before stopping treatment with this medicine, you must consult your doctor.
Like all medicines, lamotrigine can cause adverse effects, although not all people suffer from them.
Allergic reactions or potentially serious skin reactions: consult your doctor immediately.
Skin rashes may appear that can threaten the patient's life (Stevens-Johnson syndrome, toxic epidermal necrolysis) (see section 2)
Frequency: Very rare
In many cases, these symptoms can be signs of less serious adverse effects. But you should be aware that they are potentially serious. If you experience any of these symptoms:
Very common adverse effects:
These affect more than 1 in 10 people:
Common adverse effects:
These affect up to 1 in 10 people:
Uncommon adverse effects:
These may affect up to 1 in 100 people:
Rare adverse effects:
These affect up to 1 in 1,000 people:
Very rare adverse effects:
These affect up to 1 in 10,000 people:
Other adverse effects
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister pack, packaging, or bottle, after "CAD". The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Lamotrigina Kern Pharma dispersible/chewable tablets
The active ingredient is lamotrigine. Each dispersible/chewable tablet contains 200 mg of lamotrigine.
The other components are: sorbitol, calcium carbonate (E-420i), silicified microcrystalline cellulose [microcrystalline cellulose (E-460i) and anhydrous colloidal silica], crospovidone, cornstarch, talc (E-553b), blackcurrant flavor, sodium saccharin (E-954ii), anhydrous colloidal silica, and sodium stearyl fumarate (E-470a).
Appearance of the product and package contents
The tablets are white or off-white, with a modified square shape, engraved with "L" and "200" on one side and flat on the other.
Each package contains 30 dispersible/chewable tablets.
Marketing authorization holder and manufacturer
Kern Pharma, S.L.
C/Venus, 72 – Pol. Ind. Colón II,
08228 Terrassa (Barcelona)
Spain
Date of the last revision of this prospectus: October 2023
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LAMOTRIGINE KERN PHARMA 200 mg DISPERSIBLE/CHEWABLE TABLETS in October, 2025 is around 28.24 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.